Detalhe da pesquisa
1.
In Vitro Activity and Microbiological Efficacy of Gepotidacin from a Phase 2, Randomized, Multicenter, Dose-Ranging Study in Patients with Acute Bacterial Skin and Skin Structure Infections.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818823
2.
Molecular evolution perspectives on intraspecific lateral DNA transfer of topoisomerase and gyrase loci in Streptococcus pneumoniae, with implications for fluoroquinolone resistance development and spread.
Antimicrob Agents Chemother
; 49(10): 4315-26, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16189113
3.
Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes.
Antimicrob Agents Chemother
; 47(6): 1784-9, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12760849
4.
Characterization of the Streptococcus pneumoniae NADH oxidase that is required for infection.
Microbiology (Reading)
; 147(Pt 2): 431-438, 2001 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11158360
5.
The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulence.
Microbiology (Reading)
; 146 ( Pt 7): 1547-1553, 2000 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10878119
6.
Characterization of a novel fucose-regulated promoter (PfcsK) suitable for gene essentiality and antibacterial mode-of-action studies in Streptococcus pneumoniae.
J Bacteriol
; 185(6): 2051-8, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12618474
7.
A global approach to identify novel broad-spectrum antibacterial targets among proteins of unknown function.
J Mol Microbiol Biotechnol
; 6(2): 109-26, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-15044829